The appetite for weight-loss drugs has been insatiable

episode

The Pat Kenny Show not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from The Pat Kenny Show

Motoring with Geraldine Herbert 10 min · 20 Sep 2026

Trump family's deals in the Balkans 16 min · 20 Sep 2026

What were the Vikings like? 16 min · 20 Sep 2026

Russian elections 8 min · 20 Sep 2026

Pat's Sunday Paper Review 20th September 17 min · 20 Sep 2026

Trump bans CNN from the White House 18 min · 19 Sep 2026

All episodes from The Pat Kenny Show →

Report any issue

Source

Recorded13 Nov 2025

Publisherrss.podplaystudio.com

Handlerec:9619823

Show notes

The appetite for weight-loss drugs, known as glp-1 agonists, has been insatiable since they hit the market a decade ago. In 2024 global spending on them reached $54bn, a figure that is sure to rise in the coming years. As pharmaceutical firms elbow each other for a slice of the pie, the number of options will grow in 2026 All to discuss with Professor Luke O Neill , Professor of Biochemistry at the school of Immunology, Trinity College.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in